PROVIDER PROFILE · NPI 1003170416
Maali MilhemMD
PRESCRIBING · PART D · 2024
Total Rx claims
746
Beneficiaries
—
Total drug cost
$282K
Distinct drugs
16
Brand share
64.7%
Top prescribed drugs
Levothyroxine Sodium135 claims
Empagliflozin75 claims
Metformin Hcl70 claims
Semaglutide52 claims
Metformin Hcl48 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (4)
REFERRAL NETWORK
Where Maali Milhem's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 1 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| CABELL HUNTINGTON HOSPITAL INC | 12 | 46 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| CABELL HUNTINGTON HOSPITAL INC | 21 | 77 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE